News

Patients with rheumatoid arthritis who undergo immune checkpoint inhibition for metastatic non-small cell lung cancer demonstrate similar overall survival as those without RA, according to data ...
Canada grants bioAffinity Technologies new patent that protects its proprietary technology that powers its flagship product, CyPath® Lung ...
Seventy percent of Asian American and Pacific Islander women diagnosed with lung cancer were non- or never-smokers, highlighting a need to rethink lung cancer screening to reduce disparities.
Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the body, such as the bones or liver.
Learn how a lung cancer cough might feel, and the multiple treatment options available.
Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had a cigarette could be at risk of the deadly disease.
The FDA has granted quick approval to sunvozertinib (sold as Zegfrovy) a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC).
Nearly a quarter of all newly diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.
There is much to commend about Australia's lung cancer screening program, which started on July 1.
A new study reveals that air pollution, traditional herbal medicines and other environmental exposures are linked to genetic mutations that may contribute to the development of lung cancer in ...
Research from the NIH’s National Cancer Institute, an agency beleaguered by funding cuts and censorship, finds that particulate matter pollution impacts lung cancer at the DNA level.